Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Expert Opinion on Drug Metabolism & Toxicology|February 20, 2016
Clinical pharmacokinetics and pharmacodynamics of ramucirumab in the treatment of colorectal cancerValentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, et al.Cancer Treatment Reviews|October 21, 2023
AXL - a new player in resistance to HER2 blockadeAnna Adam-Artigues, Enrique J Arenas, Joaquín Arribas, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2018
Breast cancer in pregnant patients: A review of the literatureMaría Teresa Martínez, Begoña Bermejo, Cristina Hernando, et al.Oncotargets and Therapy|May 23, 2015
Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature reviewNoelia Tarazona, Lara Navarro, Juan Miguel Cejalvo, et al.Cancers|April 25, 2020
Personalized Medicine: Recent Progress in Cancer TherapyValentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, et al.Cancers|July 9, 2022
Immunological Landscape of HER-2 Positive Breast CancerSantiago Moragon, Cristina Hernando, Maria Teresa Martinez-Martinez, et al.Cancer Treatment Reviews|May 16, 2018
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancerJuan Miguel Cejalvo, Tomás Pascual, Aranzazu Fernández-Martínez, et al.Plos One|May 12, 2017
Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancerDenis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, et al.Critical Reviews in Oncology/Hematology|August 30, 2021
Fertility and breast cancer: A literature review of counseling, preservation options and outcomesSantiago Moragón, Raimondo Di Liello, Begoña Bermejo, et al.Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.Pageof 6